CAS 915759-45-4

WAY-316606

Description:

WAY-316606, with the CAS number 915759-45-4, is a chemical compound that has garnered attention in pharmacological research, particularly for its role as a selective inhibitor of certain enzymes. It is primarily studied for its potential therapeutic applications, particularly in the context of metabolic disorders and obesity. The compound exhibits a specific mechanism of action that involves modulation of metabolic pathways, which may lead to beneficial effects on energy expenditure and fat metabolism. In terms of its physical and chemical properties, WAY-316606 is characterized by its molecular structure, which includes specific functional groups that contribute to its biological activity. The compound is typically evaluated for its solubility, stability, and bioavailability, which are crucial for its efficacy as a therapeutic agent. As research continues, further insights into its pharmacokinetics, safety profile, and potential side effects are essential for understanding its viability as a drug candidate. Overall, WAY-316606 represents a promising area of study within medicinal chemistry and drug development.

BenzenesulfonaMide, 5-(phenylsulfonyl)-N-4-piperidinyl-2-(trifluoroMethyl)-

CAS: 915759-45-4

Formula: C₁₈H₁₉F₃N₂O₄S₂

Purity: %

Color and Shape: Solid

Molecular weight: 448.4797

Ref: IN-DA00GU7E

5-(Phenylsulfonyl)-N-(Piperidin-4-Yl)-2-(Trifluoromethyl)Benzenesulfonamide

CAS: 915759-45-4

5-(Phenylsulfonyl)-N-(Piperidin-4-Yl)-2-(Trifluoromethyl)Benzenesulfonamide

Purity: 98+%

Molecular weight: 448.48g/mol

Ref: 54-PC108769

WAY 316606

CAS: 915759-45-4

WAY 316606

Purity: ≥98%

Molecular weight: 448.48g/mol

Ref: 54-BUP10152

WAY 316606

CAS: 915759-45-4

WAY 316606 is an inhibitor of the secreted protein sFRP-1, an endogenous antagonist of the secreted glycoprotein Wnt.

Formula: C₁₈H₁₉F₃N₂O₄S₂

Purity: 99.65%

Color and Shape: Solid

Molecular weight: 448.48

Ref: TM-T4468

WAY 316606

CAS: 915759-45-4

WAY 316606 is a potent, orally administered small molecule that inhibits the Wnt signaling pathway by blocking the action of β-catenin. It has been shown to have potential for treating eye disorders, including age-related macular degeneration. This drug also has potential for treatment of cell and nervous system diseases such as Alzheimer's disease and Huntington's disease. WAY 316606 inhibits the transcriptional activity of the β-catenin/Tcf4 complex by binding to it and preventing its translocation into the nucleus. In addition, WAY 316606 prevents downstream activation of genes regulated by β-catenin signaling, including c-myc and cyclin D1. This drug also blocks growth factor receptor tyrosine kinases and monoclonal antibodies that activate these receptors.

Formula: C₁₈H₁₉F₃N₂O₄S₂

Purity: Min. 95%

Molecular weight: 448.48 g/mol

Ref: 3D-FP101364